Progressive Cone Dystrophy and Cone-Rod Dystrophy.
Chiang BK, Tsang SH, Sharma T, Diaconita V.
Adv Exp Med Biol. 2025;1467:61-67. doi: 10.1007/978-3-031-72230-1_12.
Progressive Cone Dystrophy and Cone-Rod Dystrophy (XL, AD, and AR).
Tsang SH, Sharma T.
Adv Exp Med Biol. 2018;1085:53-60. doi: 10.1007/978-3-319-95046-4_12.
Cone dystrophy associated with autoimmune polyglandular syndrome type 1.
Badawi A, Magliyah M, Alabbasi O, AlAbdi L, Alkuraya FS, Schatz P, ALBalawi HB, Mura M.
Sci Rep. 2023 Jul 11;13(1):11223. doi: 10.1038/s41598-023-38419-9.
Cone dystrophy with supernormal rod responses: A rare KCNV2 gene variant.
Esteves-Leandro J, Torres-Costa S, Estrela-Silva S, Santos-Silva R, Brandão E, Grangeia A, Fernandes S, Oliveira R, Falcão-Reis F, Rocha-Sousa A.
Eur J Ophthalmol. 2022 Jan;32(1):664-672. doi: 10.1177/11206721211000000. Epub 2021 Mar 11.
Optical Gap Biomarker in Cone-Dominant Retinal Dystrophy.
Oh JK, Ryu J, Lima de Carvalho JR Jr, Levi SR, Lee W, Tsamis E, Greenstein VC, Mahajan VB, Allikmets R, Tsang SH.
Am J Ophthalmol. 2020 Oct;218:40-53. doi: 10.1016/j.ajo.2020.05.016. Epub 2020 May 21.
Acquired color vision deficiency.
Simunovic MP.
Surv Ophthalmol. 2016 Mar-Apr;61(2):132-55. doi: 10.1016/j.survophthal.2015.11.004. Epub 2015 Nov 30.
Blue Cone Monochromatism.
Hartung KJ, Tsang SH, Sharma T, Diaconita V.
Adv Exp Med Biol. 2025;1467:73-75. doi: 10.1007/978-3-031-72230-1_14.
The cone dystrophies.
Simunovic MP, Moore AT.
Eye (Lond). 1998;12 ( Pt 3b):553-65. doi: 10.1038/eye.1998.145.
Blue cone monochromacy and gene therapy.
Sechrest ER, Chmelik K, Tan WD, Deng WT.
Vision Res. 2023 Jul;208:108221. doi: 10.1016/j.visres.2023.108221. Epub 2023 Mar 29.
Optical Coherence Tomography Angiography in Patients with Cone Dystrophy.
Yilmaz AC, Durukan AH, Yilmaz H, Karaca U.
Semin Ophthalmol. 2022 May 19;37(4):485-490. doi: 10.1080/08820538.2021.1985527. Epub 2021 Sep 29.
